LUCIUS 卢修斯 舒尼替尼 Sunitinib胃肠道间质瘤 晚期肾细胞癌 胰腺神经内分泌肿瘤

舒尼替尼

美国FDA批准上市产品,疗效确切
卢修斯制药(老挝)有限公司出品

Sunitinib

老挝国家食药监局批准上市
老挝国家药检所检测认证
胃肠道间质瘤

Eaca capsule contais Sunitimib malate 16.71 mg
egurvalent to Sunitinib .........

LUCÏUS

晚期肾细胞癌

. Gastrointestinal stromal tumor (GIST) afte Alesses

PHARMACEUTICALS

dstronistinal stromne tie treatmerte

.Advanced renal cell carcinoma (RCC)
ntolerance fo imatinib mesvlate
*Propressive, vell-differentiated caserost

LuciSuni

胰腺神经内分泌肿瘤

e tuenors (BNET) in eatlste
unresectable Ioeallv adusncad or matastatle Alu
Desage and Use:
GIST andRCC.
50 mg orally once daily, with or without food, 4 weeks
on trearreat follon ed by 2 weeks off
NET.

Sunitinib Capsules

.37,5 mg orally once danly, with or withiout 1o0d,
continoously withont a scheda led off-treatnent period.

12.5mg

"Dose interraptions and or dose adjustmests of 12.5 mg

FDA批准

recomiterded based on individaal safety and tolerabili
Storage: in a dry place and store at 20C 1o25C
Warning:

Rx Only

Kcep medicine out of reach of Children. De not administer
LaciSuni during Preenancy and Lictation.
PLEASESEE PACKAGE INSERT
Manufactured and Marketed by
LUCIUS

Thongmang village, Xaythany distri
Vientiane Capital, Laos

权威认证

Warning: To be sold by retali on prescnpuon
ol registered physicians only, and as directed
by the phusician

28 Capsules

口碑质量

适应症:
1、治疗使用甲磺酸伊马替尼后病情进展或不耐受的胃肠道间质瘤(GIST)。
2、晚期肾细胞癌(RCC)。
3、患有无法切除的局部晚期或转移性疾病的进展性、分化良好的胰腺神
经内分泌肿瘤(pNET)。
推荐剂量:
1、GIST和RCC:每日口服一次,每次50mg,可与食物同服或单独服
用,治疗4周,然后停药2周。
2、pNET:每日口服一次,每次37.5mg,可与食物同服或单独服用,连
续服用,无预定的停药期。
3、剂量调整:根据个人安全性和耐受性,建议剂量中断和/或剂量调整
12.5mg.